| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
to Convert Naive CD4+CD25– Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1
Division of Rheumatology and Immunology, Department of Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA 90033
IL-2 and TGF-
both have important roles in the induction and maintenance of immunologic tolerance, but whether these cytokines act separately or together to achieve this effect is poorly understood. Although others have reported that IL-2 can directly enhance forkhead box protein P3 (Foxp3) transcription factor expression by natural CD4+CD25+ regulatory T cells, in this study, we report that the role of IL-2 on the generation of peripheral regulatory CD4+ cells is indirect. Ab neutralization studies and experiments with IL-2-deficient mice have revealed that IL-2 is required for TGF- to induce naive CD4+CD25– cells to become CD25+ and express Foxp3, and develop the characteristic properties of CD4+CD25+ regulatory cells. This effect of IL-2 on the generation and expansion of these adaptive Foxp3+ regulatory cells is nonredundant, but IL-4, IL-7, and IL-15, other common 
-chain cytokines, could sustain Foxp3 expression. Because subjects with autoimmune diseases often have defects in the production of IL-2 and/or TGF-, the generation of autologous T regulatory cells ex vivo with these cytokines for transfer in vivo may have considerable therapeutic potential.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by grants from the National Institutes of Health (Grant AI-41768; to D.A.H.); Arthritis Foundation (to D.A.H. and S.G.Z.); Nora Eccles Treadwell Foundation (to D.A.H.); Arthritis National Research Foundation (to S.G.Z.); Wright Foundation (to S.G.Z.), Clinical Research Feasibility Fund (to S.G.Z.); and James H. Zumberge Faculty Research and Innovation Fund (to S.G.Z.).
2 Current address: Division of Rheumatology, Immunology and Nephrology, Zhejiang Traditional Chinese Medicine and Western Medicine Hospital, Hangzhou, 310003, People’s Republic of China.
3 Address correspondence and reprint requests to Dr. David A. Horwitz, University of Southern California, Keck School of Medicine, 2011 Zonal Avenue, Hoffman Building 711, Los Angeles, CA 90033. E-mail address: dhorwitz{at}usc.edu
4 Abbreviations used in this paper: Treg, regulatory T; GITR, glucocorticoid-induced TNF receptor; HPRT, hypoxanthine guanine phosphoribosyl transferase; SLE, systemic lupus erythematosus.
This article has been cited by other articles:
|
|
 |
|
  B. B. L. Pillemer, Z. Qi, B. Melgert, T. B. Oriss, P. Ray, and A. Ray STAT6 Activation Confers upon T Helper Cells Resistance to Suppression by Regulatory T Cells J. Immunol., July 1, 2009; 183(1): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huber, F. R. Stahl, J. Schrader, S. Luth, K. Presser, A. Carambia, R. A. Flavell, S. Werner, M. Blessing, J. Herkel, et al. Activin A Promotes the TGF-{beta}-Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells J. Immunol., April 15, 2009; 182(8): 4633 - 4640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Haribhai, W. Lin, B. Edwards, J. Ziegelbauer, N. H. Salzman, M. R. Carlson, S.-H. Li, P. M. Simpson, T. A. Chatila, and C. B. Williams A Central Role for Induced Regulatory T Cells in Tolerance Induction in Experimental Colitis J. Immunol., March 15, 2009; 182(6): 3461 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Lathrop, N. A. Santacruz, D. Pham, J. Luo, and C.-S. Hsieh Antigen-specific peripheral shaping of the natural regulatory T cell population J. Exp. Med., December 22, 2008; 205(13): 3105 - 3117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Lewis, M. Mizrahi, M. Toledano, N. DeFelice, J. L. Wright, A. Churg, L. Shapiro, and C. A. Dinarello {alpha}1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice PNAS, October 21, 2008; 105(42): 16236 - 16241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, X. Liang, A. J. Peterson, D. H. Munn, and B. R. Blazar The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation J. Immunol., October 15, 2008; 181(8): 5396 - 5404. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Samanta, B. Li, X. Song, K. Bembas, G. Zhang, M. Katsumata, S. J. Saouaf, Q. Wang, W. W. Hancock, Y. Shen, et al. TGF-{beta} and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3 PNAS, September 16, 2008; 105(37): 14023 - 14027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kaplan, L Woodworth, K Smith, J Coco, A Vitsky, and J. McPherson Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-{beta}1 in the MRL/lpr lupus mouse model Lupus, September 1, 2008; 17(9): 822 - 831. [Abstract] [PDF]
|
|
|
|
 |
|
 J. B. Samon, A. Champhekar, L. M. Minter, J. C. Telfer, L. Miele, A. Fauq, P. Das, T. E. Golde, and B. A. Osborne Notch1 and TGF{beta}1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells Blood, September 1, 2008; 112(5): 1813 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Guo, C. Iclozan, W.-K. Suh, C. Anasetti, and X.-Z. Yu CD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells J. Immunol., August 15, 2008; 181(4): 2285 - 2291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Zheng, J. Wang, and D. A. Horwitz Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-{beta} Are Resistant to Th17 Conversion by IL-6 J. Immunol., June 1, 2008; 180(11): 7112 - 7116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Singh, W. F. Carson IV, E. R. Secor Jr, L. A. Guernsey, R. A. Flavell, R. B. Clark, R. S. Thrall, and C. M. Schramm Regulatory Role of B Cells in a Murine Model of Allergic Airway Disease J. Immunol., June 1, 2008; 180(11): 7318 - 7326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qin, Y. Sui, A. C. Soloff, B. A. Fallert Junecko, D. E. Kirschner, M. A. Murphey-Corb, S. C. Watkins, P. M. Tarwater, J. E. Pease, S. M. Barratt-Boyes, et al. Chemokine and Cytokine Mediated Loss of Regulatory T Cells in Lymph Nodes during Pathogenic Simian Immunodeficiency Virus Infection J. Immunol., April 15, 2008; 180(8): 5530 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Passerini, S. E. Allan, M. Battaglia, S. Di Nunzio, A. N. Alstad, M. K. Levings, M. G. Roncarolo, and R. Bacchetta STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells Int. Immunol., March 1, 2008; 20(3): 421 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Asano, T. Watanabe, A. Kitani, I. J. Fuss, and W. Strober Notch1 Signaling and Regulatory T Cell Function J. Immunol., March 1, 2008; 180(5): 2796 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Selvaraj and T. L. Geiger Mitigation of Experimental Allergic Encephalomyelitis by TGF-{beta} Induced Foxp3+ Regulatory T Lymphocytes through the Induction of Anergy and Infectious Tolerance J. Immunol., March 1, 2008; 180(5): 2830 - 2838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Aricha, T. Feferman, S. Fuchs, and M. C. Souroujon Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia Gravis J. Immunol., February 15, 2008; 180(4): 2132 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J.A. van Wanrooij, S. C.A. de Jager, T. van Es, P. de Vos, H. L. Birch, D. A. Owen, R. J. Watson, E. A.L. Biessen, G. A. Chapman, T. J.C. van Berkel, et al. CXCR3 Antagonist NBI-74330 Attenuates Atherosclerotic Plaque Formation in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 251 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Chai, D. Coe, D. Chen, E. Simpson, J. Dyson, and D. Scott In Vitro Expansion Improves In Vivo Regulation by CD4+CD25+ Regulatory T Cells J. Immunol., January 15, 2008; 180(2): 858 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yamazaki, A. J. Bonito, R. Spisek, M. Dhodapkar, K. Inaba, and R. M. Steinman Dendritic cells are specialized accessory cells along with TGF- for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3 precursors Blood, December 15, 2007; 110(13): 4293 - 4302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Chen, S. Vodanovic-Jankovic, B. Johnson, M. Keller, R. Komorowski, and W. R. Drobyski Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease Blood, November 15, 2007; 110(10): 3804 - 3813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Evans, T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes PNAS, October 23, 2007; 104(43): 17034 - 17039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gaudreau, C. Guindi, M. Menard, G. Besin, G. Dupuis, and A. Amrani Granulocyte-Macrophage Colony-Stimulating Factor Prevents Diabetes Development in NOD Mice by Inducing Tolerogenic Dendritic Cells that Sustain the Suppressive Function of CD4+CD25+ Regulatory T Cells J. Immunol., September 15, 2007; 179(6): 3638 - 3647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Guan, P. S. Nagarkatti, and M. Nagarkatti Blockade of Hyaluronan Inhibits IL-2-Induced Vascular Leak Syndrome and Maintains Effectiveness of IL-2 Treatment for Metastatic Melanoma J. Immunol., September 15, 2007; 179(6): 3715 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Selvaraj and T. L. Geiger A Kinetic and Dynamic Analysis of Foxp3 Induced in T Cells by TGF-beta J. Immunol., June 15, 2007; 178(12): 7667 - 7677. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
